I am a breastfeeding mother and i want to know if it is safe to use RS-21592? Is RS-21592 safe for nursing mother and child? Does RS-21592 extracts into breast milk? Does RS-21592 has any long term or short term side effects on infants? Can RS-21592 influence milk supply or can RS-21592 decrease milk supply in lactating mothers?
- DrLact safety Score for RS-21592 is 3 out of 8 which is considered Low Risk as per our analyses.
- A safety Score of 3 indicates that usage of RS-21592 may cause some minor side effects in breastfed baby.
- Our study of different scientific research indicates that RS-21592 may cause moderate to no side effects in lactating mother.
- Most of scientific studies and research papers declaring usage of RS-21592 low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- While using RS-21592 We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Synthetic nucleoside which is analogue of guanine, structurally very closed related to acyclovir.Indicated for the treatment and prevention of Cytomegalovirus (CMV) in immunocompromised patients. At latest update no published data on excretion into breast milk were found. It is used in newborns and premature who are affected with CMV infection.Its low oral bioavailability hinders the passage from ingested milk towards the infant’s plasma, except in preterm babies and immediate neonatal period, which may show an increased intestinal permeability.
Several factors might affect the decision to use RS-21592 in a nursing mother. No information is available on the clinical use of RS-21592 during breastfeeding. Cytomegalovirus (CMV) can be transmitted to infants though breastmilk, with preterm and immunocompromised infants at greatest risk. No information is available on any changes in the risk of transmission if the mother is being treated with RS-21592. Although the manufacturer recommends avoiding breastfeeding during RS-21592 use because of the risk of infant drug toxicity, neonates with CMV infections are often treated directly with RS-21592. If the mother has a concurrent infection with HIV, breastfeeding is not recommended in the United States and other developed countries.
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.